YouTube Facebook LinkedIn Google+ Twitter Xingrss  

PacBio's Rise from the Hype Ashes


March 4, 2014 | PacBio seduced investors with a promise of revolution, Xconomy's Luke Timmerman says. Their first predictions failed, but now PacBio is making a name for itself in high-accuracy genomes and detecting structural variations that no one else can. Xconomy
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.